MAM
BNTX icon

Meeder Asset Management’s BioNTech BNTX Stock Holding History

Meeder Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31
Closed -$4K – 937
2022
Q3 		$4K Hold
31
– – ﹤0.01% 1618
2022
Q2 		$5K Hold
31
– – ﹤0.01% 1630
2022
Q1 		$5K Buy
+31
New +$5.21K ﹤0.01% 1778

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Meeder Asset Management's BNTX Position: Q4 2022 in Review

Meeder Asset Management sold out of BioNTech (BNTX) in Q4 2022, closing a stake of 31 shares — an estimated $4K sold.

Meeder Asset Management first reported a position in BNTX in Q1 2022 and held it in 3 quarters. The position peaked at $5K in Q2 2022. 320 funds tracked by Wall St. Rank hold BNTX as of Q4 2022.

  • Meeder Asset Management reported no remaining BioNTech position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 31 BioNTech shares in Q4 2022, an estimated $4K.
  • Meeder Asset Management first reported a position in BioNTech in Q1 2022 and held it in 3 quarters.
  • Meeder Asset Management's BioNTech position peaked at $5K in Q2 2022.
  • 320 funds tracked by Wall St. Rank held BioNTech as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.